Saluda Medical Lists on ASX, Reaffirms Fiscal 2026 Guidance
MT Newswires Live
Dec 05, 2025
Saluda Medical (ASX:SLD) said it listed on the Australian Stock Exchange following its initial public offering that raised AU$230.8 million from the issue of about 87.1 million new Chess depositary interests at AU$2.65 apiece, according to a Friday filing with the Australian bourse.
The company will start trading on the ASX under the ticker symbol "SLD" on Friday, the filing said.
Proceeds raised will be used to expand the company's sales and marketing team, provide commercial support, and for product development, the filing added.
The company reaffirmed its fiscal 2026 revenue guidance of $81.9 million, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.